Active constituents: Several constituents have been shown to
contribute to the medicinal action of mistletoe. Most notable are mistletoe lectins (also
called viscotoxins), choline derivatives, alkaloids, polypeptides, and polysaccharides. Human
pharmacological studies have found that mistletoe extract given by injection stimulates immune system function.4 5
6 Some test tube and animal studies suggest that certain mistletoe constituents,
including the alkaloids, can also kill cancer cells.7 8 Numerous
clinical trials have found that subcutaneous injections of mistletoe extracts can help people
with cancer of various organs, though some have also failed to show any benefit.9
10 There is no evidence that people with cancer would benefit from receiving
mistletoe orally.
Mistletoe’s other uses have been less rigorously studied. Preliminary trials carried
out using oral mistletoe have found it can reduce the symptoms of high blood pressure, particularly headaches and
dizziness.11 12 However, mistletoe has a small (if any) effect on
actually lowering blood pressure.13
Test tube and animal studies suggest that mistletoe extracts can stimulate insulin secretion from pancreas cells and may improve blood sugar
levels in people with diabetes.14
15 Given both mistletoe’s tradition around the world for helping people with
diabetes and these promising preclinical results, human clinical trials are needed to
establish mistletoe’s potential for this condition.
How much is usually taken? Traditionally a cold water extract
(cold infusion) is made by soaking 2–4 teaspoons (10–20 grams) of chopped
mistletoe in two cups (500 ml) of water overnight.16 This is taken first thing in
the morning and can be sweetened with honey. Another batch is left to steep during the day and
drunk at bedtime. Alternately a hot tea can be made by infusing 1 teaspoon (5 grams) of leaves
in a cup (250 ml) of just-boiled water for 5–10 minutes. Two cups (500 ml) are consumed
per day.17 A tincture, approximately 1/8 teaspoon (1/2 ml) three times per day, can
also be used.
At least three standardized, injectable extracts have been studied in Europe: Iscador,
Helixor, and Eurixor. These products are not designed for self-treatment and are not
commercially available in the United States. Iscador is the only fermented extract of the
three, and each is standardized in a different way, making comparisons between the extracts
difficult. In addition, there are different forms of each extract taken from mistletoe growing
on different host trees. Typically, one weekly injection providing 1 mg of mistletoe lectin I
per kilogram of body weight is given. People interested in subcutaneous or other injectable
forms of mistletoe should consult with a physician.
References:
1. Walker BG. The Woman’s Encyclopedia of Myths and
Secrets. San Francisco: Harper & Row, 1983, 661–3.
2. Duke JA. CRC Handbook of Medicinal Herbs. Boca Raton, FL: CRC
Press, 1985, 512–3.
3. Urech K. Mistletoe constituents and cancer therapy. J
Anthroposophical Med 1993;10:54–63.
4. Hajto T. Immunomodulatory effects of Iscador: A Viscum album
preparation. Oncology 1986;43(suppl 1):51–65.
5. Bocci B. Mistletoe (Viscum album) lectins as cytokine
inducers and immunoadjuvant in tumor therapy. A review. J Biol Reg Homeostatic Agents
1993;7:1–6.
6. Bloksma N, Schmiermann P, de Reuver M, et al. Stimulation of humoral
and cellular immunity by Viscum preparations. Planta Med 1982;46:221–7.
7. Jurin M, Zarkovic’ N, Hrzenjak M, Ilic’ Z. Antitumorous
and immunomodulatory effects of the Viscum album L preparation Isorel.
Oncology 1993;50:393–8.
8. Khwaja TA, Dias CB, Pentecost S. Recent studies on the anticancer
activities of mistletoe (Viscum album) and its alkaloids. Oncology
1986;43(suppl 1):42–50.
9. Yarnell E. Is Viscum album a potential treatment for
pancreatic cancer? HealthNotes Review 1999;6:88–90 [review].
10. Kleijnen J, Knipschild P. Mistletoe treatment for cancer. Review of
controlled trials in humans. Phytomedicine 1994;1:255–60.
11. Bowman IA. The everlasting mistletoe and the cardiovascular system.
Texas Heart Inst J 1990;17:310–4 [review].
12. O’Hare JP, Hoyt LH. Mistletoe in the treatment of hypertension.
New Eng J Med 1928;199:1207–13.
13. Weiss RF. Herbal Medicine. Gothenburg, Sweden: Ab Arcanum
and Beaconsfield, UK: Beaconsfield Publishers Ltd, 1985, 158–60.
14. Gray AM, Flatt PR. Insulin-secreting activity of the traditional
antidiabetic plant Viscum album (mistletoe). J Endocrinol
1999;160:409–14.
15. Swanson-Flatt SK, Day C, Bailey CJ, Flatt PR. Evaluation of
traditional plant treatments for diabetes: Studies in streptozotocin-diabetic mice. Acta
Diabetologica Latina 1989;26:51–5.
16. Weiss RF. Herbal Medicine. Gothenburg, Sweden: Ab Arcanum
and Beaconsfield, UK: Beaconsfield Publishers Ltd, 1985, 158–60.
17. Weiss RF. Herbal Medicine. Gothenburg, Sweden: Ab Arcanum
and Beaconsfield, UK: Beaconsfield Publishers Ltd, 1985, 158–60.
18. Weiss RF. Herbal Medicine. Gothenburg, Sweden: Ab Arcanum
and Beaconsfield, UK: Beaconsfield Publishers Ltd, 1985, 158–60.
19. Krenzelok EP, Jacobsen TD, Aronis J. American mistletoe exposures.
Am J Emerg Med 1997;15:516–20.
20. Spiller HA, Willias DB, Gorman SE, Sanftleban J. Retrospective study
of mistletoe ingestion. Clin Toxicol 1996;34:405–8.
Copyright © 2002 Healthnotes, Inc. All rights reserved.
www.healthnotes.com
Learn more about Healthnotes, the company.
Learn more about the authors of Healthnotes.
The information presented in Healthnotes is for informational
purposes only. It is based on scientific studies (human, animal, or in vitro),
clinical experience, or traditional usage as cited in each article. The results reported may
not necessarily occur in all individuals. For many of the conditions discussed, treatment with
prescription or over-the-counter medication is also available. Consult your doctor,
practitioner, and/or pharmacist for any health problem and before using any supplements or
before making any changes in prescribed medications. Information expires December 2003.